{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:37:52Z","timestamp":1789472272006,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11912-023-01357-w","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T08:02:35Z","timestamp":1674633755000},"page":"151-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current Diagnostic Tools for Breast Cancer-Related Lymphedema"],"prefix":"10.1007","volume":"25","author":[{"given":"Chirag","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Asha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00520-015-2766-x","volume":"24","author":"J Alcorso","year":"2016","unstructured":"Alcorso J, Sherman KA, Koelmeyer L, Mackie H, Boyages J. Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema. Support Care Cancer. 2016;24:139\u201346.","journal-title":"Support Care Cancer"},{"key":"1357_CR2","doi-asserted-by":"crossref","unstructured":"Whitworth P, Vicini F, Valente SA, et al. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data. J Cancer Surviv. 2022 [Epub ahead of print].","DOI":"10.1007\/s11764-022-01242-8"},{"key":"1357_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.20001","volume":"59","author":"BD Lawenda","year":"2009","unstructured":"Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59:8\u201324.","journal-title":"CA Cancer J Clin"},{"key":"1357_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/PHM.0b013e31815b6199","volume":"87","author":"YW Chen","year":"2008","unstructured":"Chen YW, Tsai HJ, Hung HC, et al. Reliability study of measurements for lymphedema in breast cancer patients. Am J Phys Med Rehabil. 2008;87:33\u20138.","journal-title":"Am J Phys Med Rehabil"},{"key":"1357_CR5","unstructured":"Hutson P. Assessing changes in arm lymphedema. Bioelectrical impedance vs. standard methods: delivering the promise. Susan G. Komen Breast Cancer Foundation Conference. 2003."},{"key":"1357_CR6","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213\u20139.","journal-title":"J Clin Oncol"},{"key":"1357_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.apmr.2008.11.016","volume":"90","author":"A Sagen","year":"2009","unstructured":"Sagen A, Karesen R, Skaane P, et al. Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery. Arch Phys Med Rehabil. 2009;90:803\u20139.","journal-title":"Arch Phys Med Rehabil"},{"key":"1357_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.NAJ.0000357172.94131.58","volume":"109","author":"MR Fu","year":"2009","unstructured":"Fu MR, Ridner SH, Armer J. Post-breast cancer. Lymphedema: Part 1. Am J Nurs. 2009;109:48\u201354.","journal-title":"Am J Nurs"},{"key":"1357_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.NAJ.0000358492.91678.78","volume":"109","author":"MR Fu","year":"2009","unstructured":"Fu MR, Ridner SH, Armer J. Post-breast cancer. Lymphedema: Part 2. Am J Nurs. 2009;109:34\u201341.","journal-title":"Am J Nurs"},{"key":"1357_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.breast.2010.05.015","volume":"19","author":"R Gartner","year":"2010","unstructured":"Gartner R, Jensen MB, Kronborg L, et al. Self-reported arm-lymphedema and functional impairment after breast cancer treatment\u2014a nationwide study of prevalence and associated factors. Breast. 2010;19:506\u201315.","journal-title":"Breast"},{"key":"1357_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/07357900902918494","volume":"28","author":"SA Czerniec","year":"2010","unstructured":"Czerniec SA, Ward LC, Refshauge KM, et al. Assessment of breast cancer-related arm lymphedema\u2014comparison of physical measurement methods and self-report. Cancer Invest. 2010;28:54\u201362.","journal-title":"Cancer Invest"},{"key":"1357_CR12","first-page":"77","volume":"30","author":"AW Stanton","year":"1997","unstructured":"Stanton AW, Northfield JW, Holroyd B, et al. Validation of an optoelectronic limb volumeter (perometer). Lymphology. 1997;30:77\u201397.","journal-title":"Lymphology"},{"key":"1357_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S1078-5884(96)80005-0","volume":"12","author":"S Tierney","year":"1995","unstructured":"Tierney S, Aslam M, Rennie K, et al. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg. 1995;12:412\u20137.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1357_CR14","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"\u2022 Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809\u201319. Prospective study demonstrating low rates of chronic lymphedema with early detection paired with early intervention.","journal-title":"Cancer"},{"key":"1357_CR15","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34:2\u201311.","journal-title":"Lymphology"},{"key":"1357_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/lrb.2010.0014","volume":"9","author":"LC Ward","year":"2011","unstructured":"Ward LC, Dylke E, Czerniec S, et al. Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol. 2011;9:47\u201351.","journal-title":"Lymphat Res Biol"},{"key":"1357_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/lrb.2006.4.51","volume":"4","author":"LC Ward","year":"2006","unstructured":"Ward LC. Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol. 2006;4:51\u20136.","journal-title":"Lymphat Res Biol"},{"key":"1357_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1365-2362.1992.tb01440.x","volume":"22","author":"LC Ward","year":"1992","unstructured":"Ward LC, Bunce IH, Cornish BH, et al. Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients. Eur J Clin Invest. 1992;22:751\u20134.","journal-title":"Eur J Clin Invest"},{"key":"1357_CR19","first-page":"85","volume":"42","author":"MS Jain","year":"2010","unstructured":"Jain MS, Danoff JV, Paul SM. Correlation between bioelectrical spectroscopy and perometry in assessment of upper extremity swelling. Lymphology. 2010;42:85\u201394.","journal-title":"Lymphology"},{"key":"1357_CR20","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ridner SH, Dietrich MS, Boyages J, et al. A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphat Res Biol. 2022;20:618\u201328. Randomized trial demonstrating benefit with prospective surveillance with bioimpedance spectroscopy coupled with early intervention as compared to surveillance with tape measurement with early intervention with patients randomized to bioimpedance surveillance have statistically significant reduction in lymphedema.","DOI":"10.1101\/2021.10.12.21264773"},{"key":"1357_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/tbj.12647","volume":"22","author":"C Shah","year":"2016","unstructured":"\u2022 Shah C, Vicini FA, Arthur D. Bioimpedance spectroscopy for breast cancer related lymphedema assessment: Clinical practice guidelines. Breast J. 2016;22:645\u201350. Clinical guidelines to assist clinicians with incorporation of bioimpedance in clinical practice.","journal-title":"Breast J"},{"key":"1357_CR22","first-page":"184","volume":"36","author":"C Shah","year":"2013","unstructured":"Shah C, Vicini F, Beitsch P, et al. The use of bioimpedance spectroscopy to monitor intervention in patients treated for breast cancer lymphedema. Lymphology. 2013;36:184\u201392.","journal-title":"Lymphology"},{"key":"1357_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/tbj.13618","volume":"25","author":"C Shah","year":"2019","unstructured":"Shah C. Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: an ounce of prevention. Breast. 2019;25:1323\u20135.","journal-title":"Breast"},{"key":"1357_CR24","first-page":"1","volume":"42","author":"FM Boccardo","year":"2009","unstructured":"Boccardo FM, Ansaldi F, Bellini C, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology. 2009;42:1\u20139.","journal-title":"Lymphology"},{"key":"1357_CR25","doi-asserted-by":"publisher","first-page":"b5396","DOI":"10.1136\/bmj.b5396","volume":"340","author":"M Torres Lacomba","year":"2010","unstructured":"Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396.","journal-title":"BMJ"},{"key":"1357_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1016591121762","volume":"75","author":"RC Box","year":"2002","unstructured":"Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75:51\u201364.","journal-title":"Breast Cancer Res Treat"},{"key":"1357_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/lrb.2014.0035","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12:289\u201394.","journal-title":"Lymphat Res Biol"},{"key":"1357_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fonc.2018.00197","volume":"8","author":"PW Whitworth","year":"2018","unstructured":"Whitworth PW, Shah C, Vicini F, Cooper A. Preventing breast cancer-related lymphedema in high-risk patients: the impact of a structured surveillance protocol using bioimpedance spectroscopy. Front Oncol. 2018;8:197.","journal-title":"Front Oncol"},{"key":"1357_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10549-016-3993-7","volume":"160","author":"EJ Yang","year":"2016","unstructured":"Yang EJ, Ahn S, Kim EK, et al. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience. Breast Cancer Res Treat. 2016;160:269\u201376.","journal-title":"Breast Cancer Res Treat"},{"key":"1357_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-020-05953-3","volume":"185","author":"LA Koelmeyer","year":"2021","unstructured":"Koelmeyer LA, Moloney E, Boyages J, et al. Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study. Breast Cancer Res Treat. 2021;185:401\u201312.","journal-title":"Breast Cancer Res Treat"},{"key":"1357_CR31","doi-asserted-by":"publisher","first-page":"P4","DOI":"10.1158\/0008-5472.SABCS11-P4-12-08","volume":"71","author":"NL Stout","year":"2011","unstructured":"Stout NL, Pfalzer L, Levy E, et al. Five year preliminary outcomes of a prospective surveillance model to reduce upper extremity morbidity related to breast cancer treatment. Cancer Res. 2011;71:P4-1208.","journal-title":"Cancer Res"},{"key":"1357_CR32","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/cncr.27472","volume":"118","author":"LH Gerber","year":"2012","unstructured":"Gerber LH, Stout NL, Schmitz KH, et al. Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care. Cancer. 2012;118:2201\u20136.","journal-title":"Cancer"},{"key":"1357_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2522\/ptj.20100167","volume":"92","author":"NL Stout","year":"2012","unstructured":"\u2022 Stout NL, Pfalzer LA, Springer B, et al. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92:152\u201363. Study demonstrating cost-effectiveness of prospective BCRL surveillance.","journal-title":"Phys Ther"},{"key":"1357_CR34","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1200\/JCO.21.02567","volume":"40","author":"VS Paramanandam","year":"2022","unstructured":"Paramanandam VS, Dylke E, Clark GM, et al. Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial. J Clin Oncol. 2022;40:2004\u201312.","journal-title":"J Clin Oncol"},{"key":"1357_CR35","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Breast Cancer V.2.2022."},{"key":"1357_CR36","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Survivorship V.3. 2021."},{"key":"1357_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/ptj\/pzx050","volume":"97","author":"K Levenhagen","year":"2017","unstructured":"Levenhagen K, Davies K, Perdomo M, et al. Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association. Phys Ther. 2017;97:729\u201345.","journal-title":"Phys Ther"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-023-01357-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-023-01357-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-023-01357-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T21:16:50Z","timestamp":1677100610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-023-01357-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s11912-023-01357-w","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"25 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chirag Shah serves as a consultant for ImpediMed, PreludeDX, Videra Surgical, and eviCore and received grants from Varian Medical Systems, VisionRT, and PreludeDx; Frank Vicini serves as a consultant for ImpediMed; and Wafa Asha declares no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}